Skip to main content

Table 2 Distribution of Short Form-36 subscale scores by some socio-demographic and disease-related characteristics of patientsa

From: Quality of life and related factors among chronic hepatitis B-infected patients: a multi-center study, Turkey

Variable

Physical functioning

Role physical

Role emotional

Vitality

Mental health

Social functioning

Bodily pain

General health

Physical component score

Mental component score

Gender

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

 Male

90 (70;100)

100 (50;100)

100 (33,3;100)

55 (45;75)

72 (56;84)

87,5 (62,5;100)

100 (77,5;100)

65 (50;75)

79 (61,5;86)

74 (54,9;82,3)

 Female

80 (55;100)

100 (25;100)

100 (0;100)

50 (35;65)

64 (48;80)

87,5 (50;100)

80 (55;100)

60 (40;70)

68,5 (47;84)

64,1 (44,6;80,8)

Marriage status

p:0,376

p:0,069

p :0,005

p:0,292

p :<0,001

p :<0,001

p:0,378

p:0,073

p:0,725

p :0,009

 Married

90 (65;100)

100 (50;100)

100 (33,3;100)

50 (40;70)

68 (52;84)

87,5 (62,5;100)

90 (67,5;100)

65 (45;75)

76 (55,5;84)

71 (51,5;80,8)

 Single

90 (65;100)

100 (43,7;100)

100 (33,3;100)

55 (40;75)

66 (48;80)

87,5 (50;100)

90 (67,5;100)

60 (40;75)

75 (54,5;86)

67,9 (46,9;81,2)

Education level

p :<0,001

p :<0,001

p :0,011

p :<0,001

p :<0,001

p :0,013

p :<0,001

p :<0,001

p :<0,001

p :<0,001

 Elementery school and under

85 (55;100)

100 (25;100)

100 (33,3;100)

50 (40;65)

68 (52;84)

87,5 (62,5;100)

90 (65;100)

60 (45;70)

71,5 (52;84)

68,5 (48,8;80,8)

 Middle school

85 (60;100)

100 (25;100)

100 (33,3;100)

55 (40;70)

68 (52;80)

75 (62,5;100)

90 (67,5;100)

60 (40;70)

72 (52;84)

68,4 (48,8;80,8)

 High school

90 (70;100)

100 (50;100)

100 (33,3;100)

55 (40;75)

68 (52;80)

87,5 (62,5;100)

100 (67,5;100)

60 (45;75)

78 (56;86)

72,3 (50,5;81,9)

 University

95 (80;100)

100 (75;100)

100 (33,3;100)

60 (45;75)

72 (56;84)

87,5 (62,5;100)

100 (77,5;100)

65 (50;75)

80 (66;87)

74,6 (56,6;83,3)

Regular income

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

 Yes

95 (70;100)

100 (50;100)

100 (66,7;100)

55 (45;75)

72 (56;84)

87,5 (62,5;100)

100 (77,5;100)

65 (50;75)

80 (62;86)

74,8 (56,8;82)

 No

80 (50;95)

75 (25;100)

66,7 (0;100)

50 (35;65)

64 (48;80)

75 (50;100)

77,5 (55;100)

55 (40;70)

67,5 (45;83)

62 (43,1;78,6)

Family members with hepatitis B

p :0,003

p :0,003

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

 Present

85 (60;100)

100 (25;100)

100 (33,3;100)

50 (40;70)

68 (52;80)

87,5 (62,5;100)

90 (67,5;100)

60 (45,70)

73,5 (53,5;84)

68,3 (48,6;80,8)

 Not

90 (70;100)

100 (50;100)

100 (33,3;100)

55 (40;70)

70 (52;84)

87,5 (62,5;100)

100 (67,5;100)

65 (45;75)

78 (57;86)

72,6 (52,8;82,1)

Received treatment for hepatitis B

p :<0,001

p :0,001

p :0,016

p:0,164

p:0,481

p:0,763

p:0,712

p :0,006

p :<0,001

p :0,012

 Yes

85 (60;100)

100 (25;100)

100 (33,3;100)

55 (40;70)

68 (52;80)

87,5 (62,5;100)

90 (67,5;100)

60 (45;70)

74 (54,5;84)

69,4 (50;80,8)

 No

90 (65;100)

100 (50;100)

100 (33,3;100)

50 (40;70)

68 (52;84)

87,5 (62,5;100)

90 (67,5;100)

65 (45;75)

77 56,5;85,8)

71,5 (50,5;81,4)

Other chronic disease

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

 Present

75 (50;95)

75 (0;100)

66,7 (0;100)

50 (35;60)

64 (48;80)

75 (50;100)

77,5 (55;100)

55 (35;70)

64,5 (43;82)

63,3 (41,2;79,2)

 Not

90 (70;100)

100 (50;100)

100 (33,3;100)

55 (45;75)

68 (52;84)

87,5 (62,5;100)

100 (77,5;100)

65 (50;75)

78 (60;86)

72,8 (53,6;82)

Hospital

p :<0,001

p :<0,001

p :<0,001

p:0,291

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

p :<0,001

 Training hospital

95 (73,7;100)

100 (75;100)

100 (66,7;100)

50 (45;70)

72 (56;84)

100 (62,5;100)

100 (77,5;100)

65 (50;75)

80,5 (62,5;85)

75,7 (57,6;81,2)

 University hospital

85 (60;100)

100 (25;100)

100 (33,3;100)

55 (40;70)

64 (52;80)

87,5 (62,5;100)

90 (67,5;100)

60 (45;75)

73 (52,7;84)

67,6 (48,8;80)

 Other

80 (55;100)

75 (25;100)

66,7 (0;100)

55 (35;70)

64 (48;80)

75 (50;100)

77,5 (55;100)

60 (40;70)

67 (47,4;83)

61,2 (43,1;80)

HBeAg status

p:0,877

p:0,079

p :0,034

p:0,135

p:0,357

p :0,014

p:0,466

p :0,014

p:0,082

p :0,010

 Positive

90 (65;100)

100 (25;100)

100 (33,3;100)

50 (40;70)

68 (52;80)

87,5 (50;100)

90 (67,5;100)

60 (45;70)

74 (54,5;84)

68,6 (48,7;80,8)

 Negative

90 (65;100)

100 (50;100)

100 (33,3;100)

55 (40;70)

68 (52;84)

87,5 (62,5;100)

90 (67,5;100)

60 (45;75)

76 (55,5;85)

70,8 (50,8; 81)

  1. aValues were not normally distributed; thus; median (% 25; % 75) scores are presented in cells, bold data reflected a statistical significance